07 October 2021

PSYCH | Investor Summit
Data & Technology

Presenting Companies

Mind Cure combines psychedelic research, technology, and medicines to optimise mental health care for clinicians and their clients.medicine through a network of clinics and clinical research sites.

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites.

aNUma creates digital therapeutics at the intersection of psychedelics and virtual reality. Embodied group interaction supports the psychedelic experience, achieving target outcomes more reliably with reduced therapist workload.

Speakers

Kelsey Ramsden

Kelsey Ramsden

President and CEO, Mind Cure
More Info
Ronan Levy

Ronan Levy

Co-founder and Executive Chairman, Field Trip Health
More Info
Reid Robison

Reid Robison

Director and Chief Medical Officer, Novamind
More Info
Joe Hardy

Joe Hardy

Co-founder and Chief Science Officer, aNUma
More Info
Nanea Reeves

Nanea Reeves

CEO, TRIPP
More Info
Anne Katrin Schlag

Anne Katrin Schlag

Head of Research, Drug Science
More Info
David Glowacki

David Glowacki

Researcher, CiTIUS Intelligent Technologies Research Centre
More Info
Yeji Jesse Lee

Yeji Jesse Lee

Journalist, Business Insider
More Info
Zoe Cormier

Zoe Cormier

Author
More Info
Victoria Dekker

Victoria Dekker

Editorial Correspondent, PSYCH
More Info

Looking for Capital?

Apply now to partner with PSYCH and showcase your brand to our global investment audience.
  • Present to an audience of investors in one of our 15-minute pitch slots
  • Have our team introduce you to companies and individuals actively looking to invest
  • As a partner you will also be included in the PSYCH report have a unique profile page on the PSYCH website as well as in-event branding and a virtual booth

An Investor Looking to Attend?

Register your tickets and secure your place now.
  • Discover the industry’s most promising investment opportunities
  • Network with investors industry leaders and CEOs from some of the most exciting enterprises in the Psychedelic space
  • Join exclusive discussion rooms and get personalised introductions
  • Hear from and meet our expert speakers offering invaluable insights into this nascent industry

The Psychedelics Newsletter

Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.